Quintana denies use of banned drug after Tour de France disqualification

PARIS: Colombian Nairo Quintana on Wednesday denied taking a banned pain medication after he was retrospectively disqualified from this year’s Tour de France over a positive tramadol test result.

Former two-time runner-up Quintana, 32, finished sixth overall in the race that ended on July 24.

The pain medication has been on a list of International Cycling Union (UCI) prohibited substances since 2019.

“I know nothing about the use of this substance and deny ever having used it in my career,” Quintana, who is due to take part in the Vuelta a Espana beginning on Friday in the Netherlands, said in a statement published to Twitter.

“With my team of lawyers we are exhausting all avenues to mount my defense.”

Tramadol is only banned in competition and while Quintana has been disqualified from the Tour after testing positive for the substance on both July 8 and 13, he will not be banned from future races.

The UCI said Quintana “has been sanctioned for an infringement of the in-competition ban on using tramadol... with the aim of protecting the safety and health of riders in light of the side-effects of this substance.”

The governing body added that “the analyzes of two dried blood samples... revealed the presence of tramadol and its two main metabolites.”

Quintana has 10 days to appeal the decision to the Court of Arbitration for Sport (CAS), the UCI said.

“As this is a first offense, Nairo Alexander Quintana Rojas is not declared ineligible and can therefore participate in competitions,” it added.

Quintana’s Arkea-Samsic team said they were aware of the decision but would “make no further comment.”

The team did not say whether Quintana would still take part in the Vuelta but the Grand Tour’s race director, Javier